HomeHealthcare & Life SciencesMedical Devices Radiopharmaceutical Synthesizer Market

Canada Radiopharmaceutical Synthesizer Market Size & Outlook, 2025-2033


Canada Radiopharmaceutical Synthesizer Market Insights

  • Based on Reed Intelligence findings, the Canada Radiopharmaceutical Synthesizer Market reached USD 253.62 Million in 2024 and is estimated to attain USD 371.89 Million by 2033.
  • From 2026 to 2033, the Canada market is expected to grow at a steady CAGR of 4.38%.
  • Within the Modality category, PET dominated in 2024 in terms of market size contribution.
  • Over the forecast period, Others is forecasted to deliver the fastest growth, positioning it as the most lucrative Modality segment.

Other Key Findings


  • As of 2024, Canada held 8.1% of the global Radiopharmaceutical Synthesizer Market size.
  • By 2033, United States is anticipated to capture the largest share of the global Radiopharmaceutical Synthesizer Market.
  • In North America, United States is expected to lead the regional Radiopharmaceutical Synthesizer Market size by 2033.
  • Canada will remain the fastest-growing market in North America, reaching USD 373.03 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 253.62 Million
Market Size In 2033 USD 371.89 Million
Largest segment PET
Units Revenue in USD Million
CAGR 4.38% (2025-2033)
Segmnetation Covered
Modality
  1. PET
  2. SPECT
  3. Others
Application
  1. Oncology
  2. Cardiology
  3. Neurology
  4. Others
Radioisotope
  1. Fluorine-18
  2. Carbon-11
  3. Gallium-68
  4. Others
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends

Related Reports